Geographic Variation and Racial Disparities in Adoption of Newer Glucose-Lowering Drugs with Cardiovascular Benefits among US Medicare Beneficiaries with Type 2 Diabetes

View Resource

Analyzes the use of glucose-lowering drugs (GLDs) among people with type 2 diabetes, utilizing 2017-2018 Medicare Part D beneficiary claims data. Identifies rural-urban and racial disparities in GLD initiation rates, and discusses factors influencing equitable access to cardiovascular treatment.

Wei-Han Chen, Yujia Li, Lanting Yang, et al.

Plos ONE, 19(1), e0297208

01/2024

Document

Access · Cardiovascular disease · Diabetes · Health disparities · Pharmacy and prescription drugs · Racial and ethnic groups · Rural-urban differences · Statistics and data